New Treatment Mesothelioma – Gendicine, The Latest Great Hope For Cancer And How to Seek Treatment.
Gendicine works by combining p53 gene, a tumor suppressor, with the virus utility. When Gendicine virus is then injected into cancerous tumors, viruses insert p53 gene in cancer cells. After the p53 gene in cancer cells, causes self-destruction. Clinical trials have demonstrated 64% success rate in this combined treatment with radiation therapy.
Dr. Li Dinggang is a person responsible for the success of this new therapy. He is an oncologist who studied for five years at the Johns Hopkins University in the 1990s. Since 1997, has partnered with Dr. Peng Zhaohui, chairman and CEO of pharmaceutical company in China, SiBiono to develop Gendicine. In 50 years, Dr. Dinggang is the director of the Center for Gene Therapy in China and is also active in the care of cancer patients in Beijing Hospital Haidan.
Dr. Dinggang that any request for cancer patients who are interested in therapy Gendicine submit their medical case histories in English and translated into Chinese. After reviewing the history of the case in China, he will respond with an assessment of whether you should continue to seek entry into the hospital for treatment Haidan.
Read more…